loader image
Saturday, November 29, 2025
70.1 F
McAllen
- Advertisement -

Joining Forces to Promote COVID-19 Vaccines for Pregnant Women and Breastfeeding Moms

Translate to Spanish or other 102 languages!

We have also determined that the available COVID-19 vaccines are safe and effective and that the benefits of vaccination far outweigh the risk. DHR Health Images

Mega Doctor News

- Advertisement -

Sohail Rao, M.D., MA, DPhil, CEO of DHR Health Institute of Research and Development, and Efraim Vela, M.D., Chief Medical Officer of DHR Health Women’s Hospital have concluded that based on the available data that is supported by observations in our high-volume Women’s Hospital – a Level IV Maternal Facility, pregnant women are more susceptible to SARS- CoV-2 infection and getting a COVID-19 vaccine can protect them from severe illness. 

Additionally, after reviewing all the available scientific data, we have also determined that the available COVID-19 vaccines are safe and effective and that the benefits of vaccination far outweigh the risk. We therefore recommend that all pregnant women, those trying to get pregnant and/or breast feeding should seriously consider getting vaccinated.​

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.

Educating Older Adults On Age-Related Weight Gain, Dec. 5th

The “Living with Weight Gain” program is part of STHS & Prominence Health’s “Senior Living Seminar Series,” which focuses on providing essential education on common health issues affecting the elderly population
- Advertisement -
×